Literature DB >> 12805397

Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome.

Anton Sandhofer1, Markus Laimer, Christoph F Ebenbichler, Susanne Kaser, Bernhard Paulweber, Josef R Patsch.   

Abstract

OBJECTIVE: In obesity, plasma leptin is high and soluble leptin receptor (sOb-R) levels are low, resulting in a low fraction of bound leptin. The aim of this study was to investigate the influence of insulin resistance (IR) and the metabolic syndrome (MS) on sOb-R concentration and the bound-free ratio of leptin. RESEARCH METHODS AND PROCEDURES: sOb-R, leptin levels, and homeostasis model assessment (HOMA) index for IR were determined in 76 middle-aged obese or overweight men.
RESULTS: Concentration of sOb-R and soluble receptor-bound fraction of leptin were lowest in the highest tertile of HOMA-IR. sOb-R and the bound-free ratio of leptin correlated with HOMA-IR, leptin concentration, and waist-to-hip ratio independently of age, BMI, and fat mass. Leptin and waist-to-hip ratio were the sole independent determinants of sOb-R concentration, and BMI, HOMA-IR, and visceral adipose tissue were independent determinants of the bound fractin of leptin. sOb-R concentration and the bound fraction of leptin decreased with increasing numbers of components of the MS, resulting in lower sOb-R concentration and a lower fraction of bound leptin in men with the MS. DISCUSSION: IR and abdominal obesity are associated with low sOb-R concentration and low bound-free ratio of leptin independent of fat mass. Low sOb-R concentration and low bound-free ratio of leptin segregate with components of the MS. We suggest that low sOb-R levels and a low fraction of specifically bound leptin are markers of leptin resistance, which is independently associated with IR and abdominal obesity and may constitute an additional component of the MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805397     DOI: 10.1038/oby.2003.106

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  17 in total

1.  Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes.

Authors:  J Zaletel; D Pongrac Barlovic; J Prezelj
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

Review 2.  Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance.

Authors:  Giovanni Tarantino; Silvia Savastano; Annamaria Colao
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

3.  Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample.

Authors:  Erik Ingelsson; Martin G Larson; Xiaoyan Yin; Thomas J Wang; James B Meigs; Izabella Lipinska; Emelia J Benjamin; John F Keaney; Ramachandran S Vasan
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

Review 4.  Adipocytokines and liver disease.

Authors:  Yoshihiro Kamada; Tetsuo Takehara; Norio Hayashi
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

5.  Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels.

Authors:  Qi Sun; Marilyn C Cornelis; Peter Kraft; Lu Qi; Rob M van Dam; Cynthia J Girman; Cathy C Laurie; Daniel B Mirel; Huizi Gong; Chau-Chyun Sheu; David C Christiani; David J Hunter; Christos S Mantzoros; Frank B Hu
Journal:  Hum Mol Genet       Date:  2010-02-17       Impact factor: 6.150

Review 6.  Nutritional regulation of leptin signaling.

Authors:  Catherine Ribiere; Charles Plut
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

7.  Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Krasimira Aleksandrova; Mazda Jenab; H Bas Bueno-de-Mesquita; Veronika Fedirko; Rudolf Kaaks; Annekatrin Lukanova; Fränzel J B van Duijnhoven; Eugene Jansen; Sabina Rinaldi; Isabelle Romieu; Pietro Ferrari; Neil Murphy; Marc J Gunter; Elio Riboli; Sabine Westhpal; Kim Overvad; Anne Tjønneland; Jytte Halkjær; Marie-Christine Boutron-Ruault; Laure Dossus; Antoine Racine; Antonia Trichopoulou; Christina Bamia; Philippos Orfanos; Claudia Agnoli; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Petra H Peeters; Eric J Duell; Esther Molina-Montes; J Ramón Quirós; Miren Dorronsoro; Maria-Dolores Chirlaque; Aurelio Barricarte; Ingrid Ljuslinder; Richard Palmqvist; Ruth C Travis; Kay-Tee Khaw; Nicholas Wareham; Tobias Pischon; Heiner Boeing
Journal:  Eur J Epidemiol       Date:  2014-05-04       Impact factor: 8.082

8.  A paleolithic diet is more satiating per calorie than a mediterranean-like diet in individuals with ischemic heart disease.

Authors:  Tommy Jönsson; Yvonne Granfeldt; Charlotte Erlanson-Albertsson; Bo Ahrén; Staffan Lindeberg
Journal:  Nutr Metab (Lond)       Date:  2010-11-30       Impact factor: 4.169

9.  Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.

Authors:  Qi Sun; Rob M van Dam; James B Meigs; Oscar H Franco; Christos S Mantzoros; Frank B Hu
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

10.  Prospective Study of Long-Term Interrelationships Among Adiposity-Associated Biomarkers in Women.

Authors:  Megu Y Baden; Frank B Hu; Tianyi Huang
Journal:  Obesity (Silver Spring)       Date:  2019-12-31       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.